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Abstract
Background: Uropathogenic strains of Escherichia coli cause symptomatic infections whereas asymptomatic
bacteriuria (ABU) strains are well adapted for growth in the human urinary tract, where they establish long-term
bacteriuria. Human urine is a very complex growth medium that could be perceived by certain bacteria as a
stressful environment. To investigate a possible imbalance between endogenous oxidative response and
antioxidant mechanisms, lipid oxidative damage estimated as thiobarbituric acid reactive substances (TBARS)
content was evaluated in twenty-one E. coli belonging to various pathovars and phylogenetic groups. Antioxidant
defense mechanisms were also analysed.
Results: During exponential growth in urine, TBARS level differs between strains, without correlation with the ability
to grow in urine which was similarly limited for commensal, ABU and uropathogenic strains. In addition, no
correlation between TBARS level and the phylogroup or pathogenic group is apparent. The growth of ABU strain
83972 was associated with a high level of TBARS and more active antioxidant defenses that reduce the imbalance.
Conclusions: Our results indicate that growth capacity in urine is not a property of ABU strains. However, E. coli
isolates respond very differently to this stressful environment. In strain ABU 83972, on one hand, the increased level
of endogenous reactive oxygen species may be responsible for adaptive mutations. On the other hand, a more
active antioxidant defense system could increase the capacity to colonize the bladder.
Keywords: Escherichia coli, Urine, Oxidative stress, Adaptation, Diversity
Background
Escherichia coli is a highly versatile bacterial species. Com-
mensal E. coli strains are normal inhabitants of the human
colon [1], but pathogenic strains of E. coli can cause intes-
tinal and extraintestinal diseases of which urinary tract
infections (UTIs) rank first [2]. Population genetic studies
based on both multi-locus enzyme electrophoresis and
various DNA markers have identified four major phylo-
genetic groups A, B1, B2, and D and a potential fifth group
E, among E. coli strains [3–5]. Several studies have
demonstrated a relationship between pathogenicity and
phylogenetic groups. Clones responsible for human
extraintestinal infections frequently belong to B2, and to a
lesser extent D, phylogenetic groups, whereas commensal
population strains are most common in groups A and B1
[6,7].
UTIs are the most common human infectious diseases
and are a major cause of morbidity. It is estimated that
there are about 150 million cases in the world per year
[8]. Uropathogenic strains of E. coli (UPEC) are respon-
sible for more than 80% of all UTIs [9]. Virulence fac-
tors, such as adhesins, toxins and siderophores enhance
the ability of UPEC to cause UTIs [10]. The ability to
grow in human urine is certainly also a necessary criter-
ion for the colonization of the bladder [11]. Indeed, the
ability of E. coli strains to survive and use resources
available in urine efficiently is an important adaptation
to the urinary tract [12]. This is illustrated by the
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asymptomatic bacteriuria (ABU) strains that colonise the
urinary tract but do not cause disease. E. coli 83972, the
ABU strain prototype, which is unable to express func-
tional type 1, P and F1C fimbriae, grows extremely well
in urine. Its growth rate is high enough to overcome the
losses due to micturition [11].
Endogenous reactive oxygen species (ROS), such as
hydrogen peroxide, superoxide anion radical and hy-
droxyl radicals are generated continuously in cells grown
aerobically. They are responsible for damages on nucleic
acids (RNA and DNA), as well as proteins and lipids,
leading to cell death [13,14] (Figure 1a). Defense
mechanisms against the damaging effects of oxidative
stress involve both enzymatic components, such as cata-
lases and superoxide dismutases (SOD), and nonenzy-
matic components, such as glutathione-dependant
reduction systems (Figure 1b).
It has been demonstrated that growth under starvation
conditions generates oxidative stress and significant
changes in glutathione homeostasis [15–17]. The
increased level of ROS comes from the imbalance be-
tween production and antioxidant mechanisms. Human
urine is a high-osmolarity, moderately oxygenated, iron
and nutrient-limited environment [18–21]. Therefore,
growth in urine could be perceived as a stressful envir-
onment. In order to evaluate the importance of en-
dogenous oxidative stress of growing cells in urine,
oxidative damages to lipids were assayed in a range of E.
coli strains representative of various pathovars and
phylogenetic groups. Antioxidant defense mechanisms
in four representatives of these E. coli strains were also
analysed.
Methods
Strains
The twenty-one E. coli strains used in this study are
described in Table 1; nine were pathogenic, three were
commensal and nine ABU. The archetypal UPEC strain
CFT073 was originally isolated from the blood and urine
of a woman admitted to the University of Maryland
(a)
(b)
Figure 1 Scheme illustrating the effects of reactive oxygen species (ROS) into the cell (a) and antioxidant defense mechanisms (b)
evaluated in this work. (a) Growth in the presence of reactive oxygen species (ROS): superoxide radical [O2
.-], hydrogen peroxide [H2O2], hydroxyl
radical [OH-] and hydroperoxyl radical [HOO-]. These ROS can damage nucleic acids (RNA and DNA) as well as proteins and lipids, leading to cell
death. (b) The superoxide dismutases (SOD), which are cytosolic (Mn-SOD and Fe-SOD) and periplasmic (Cu-SOD) allow O2
.- detoxification. The
catalase activity responsible for the reduction of H2O2 to H2O is effected by two hydroperoxydases [hydroperoxydase I (HPI) and hydroperoxydase
II (HPII)], and the alkyl hydroperoxydase (AhpC). The glutathione is synthetised from glutamate, cysteine and glycine, by 2 unrelated ligases: the γ-
glutamylcysteine synthetase (GshA) and the glutathione synthetase (GshB). The glutathione oxidoreductase (Gor) reduces glutathione disulfide
(GSSG), which is formed upon oxidation. The glucose 6-phosphate dehydrogenase (G6PDH) allows indirectly the reduction of NADP to NADPH.
The Fenton reaction is the result of electron transfer from donor to H2O2 catalyzed by iron Fe
3+. The stars show dosages effected in this study.
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Medical System [22]. Seven other UPEC prototypes, E.
coli UTI 89, J96, UMN026, IAI39, IAI74, IH11128 and
536, were also studied [23–25]. E. coli ABU 83972, the
archetypal ABU strain, is a clinical isolate capable of
long-term bladder colonization [26]. Eight other ABU
strains were also included [27]. E. coli K-12 MG 1655, a
commensal, laboratory derived strain, was originally iso-
lated from the faeces of a convalescent diphtheria pa-
tient in Palo Alto in 1922 [28]. E. coli IAI1 is a
commensal strain isolated from faeces of a young,
healthy, military conscript in the 1980s in France [6]. E.
coli ED1a, isolated in the 2000s from faeces of a healthy
man in France, belongs to a human-specific, widespread,
commensal clone that is increasing in frequency [29]. Fi-
nally, an enterohaemorrhagic E. coli (EHEC) O157:H7
Sakai strain isolated during an outbreak in Sakai City,
Japan, in 1996 was studied [30].
Growth conditions, dissolved oxygen saturation and cell
extracts
The study was performed in Luria Bertani (LB) broth, a
nutritionally rich medium and in human urine. Three
independent batches of urine from healthy volunteers
were used. Midstream urine was collected over 24 hours
from healthy male volunteers, with no history of UTI or
antibiotic use in the last two months. The urine was
pooled, centrifuged, filtered (filter size 0.22μm) and
stored at −20°C. The growth experiments were assayed
using 96 well plates and OD600 was measured with a
Tecan Infinite M200 plate reader. For the preparation of
cell extracts, aliquots of 40 ml of pooled urine or LB
broth in 50 ml vials were inoculated with the appropri-
ate volume of the overnight culture to obtain 2 x 105
bacteria/ml. Each experiment was performed in triplicate
and repeated in 3 different batches of urine or LB broth.
Cells were grown at 37°C under microaerobic conditions
(1% O2). Dissolved oxygen saturation was measured by
luminescence with a measure probe (Hach Lange
GmbH) in the different media during the exponential
growth phase. The measure was repeated at least four
times. Cultures were sampled in mid-exponential growth
phase and 30 min after the beginning of stationary
phase. Aliquots of 40 ml of culture were centrifuged at
4500 rpm at +4°C for 15 min. The bacteria were washed
Table 1 Comparison of TBARS content of twenty-one E. coli belonging to different pathovars and phylogenetic groups
during exponential growth in pooled human urine and LB broth
Urine LB broth Urine vs LB
Strains Phylo-groups Virulence groups TBARS* p** TBARS p p
ABU 57 A ABU 9.0 ± 1.7 p = 0.835 7.1 ± 0.7 p = 1.000 p= 0.995
ABU83972 B2 ABU 7.3 ± 1.0 6.4 ± 0.1 p= 1.000
ABU 5 D ABU 7.2 ± 1.1 p = 1.000 6.3 ± 1.1 p = 1.000 p= 1.000
IH11128 B2 UPEC 6.7 ± 2.0 p = 1.000 6.1 ± 0.4 p = 1.000 p= 1.000
IAI 74 B2 UPEC 6.6 ± 0.9 p = 1.000 6.1 ± 0.7 p = 1.000 p= 1.000
ABU 63 B2 ABU 6.6 ± 1.2 p = 1.000 5.8 ± 0.9 p = 1.000 p= 1.000
IAI 39 D UPEC 6.6 ± 1.5 p = 1.000 7.1 ± 0.7 p = 1.000 p= 1.000
CFT073 B2 UPEC 6.3 ± 0.9 p = 0.999 5.9 ± 0.7 p = 1.000 p= 1.000
ABU 27 B2 ABU 5.6 ± 0.9 p = 0.905 4.9 ± 0.5 p = 0.976 p= 1.000
ABU 64 B2 ABU 5.6 ± 0.4 p = 0.866 6.8 ± 0.2 p = 1.000 p= 1.000
UMN 026 D UPEC 5.2 ± 1.1 p = 0.458 6.2 ± 0.6 p = 1.000 p= 1.000
ED1a B2 commensal 5.2 ± 1.1 p = 0.542 4.9 ± 0.2 p = 0.979 p= 1.000
536 B2 UPEC 5.1 ± 1.0 p = 0.458 6.3 ± 1.7 p = 1.000 p= 1.000
J96 B2 UPEC 5.0 ± 1.1 p = 0.653 5.3 ± 1.4 p = 0.998 p= 1.000
ABU 20 B2 ABU 4.9 ± 0.9 p = 0.307 4.3 ± 1.2 p = 0.743 p= 1.000
IAI1 B1 commensal 4.3 ± 0.7 p = 0.075 4.4 ± 0.3 p = 0.789 p= 1.000
Sakai E EHEC 3.9 ± 0.4 p = 0.016 4.6 ± 0.7 p = 0.900 p= 1.000
UTI 89 B2 UPEC 3.8 ± 0.6 p = 0.015 5.1 ± 0.1 p = 0.996 p= 1.000
ABU 38 B1 ABU 3.8 ± 0.8 p = 0.012 4.5 ± 0.1 p = 0.838 p= 1.000
ABU 62 B1 ABU 3.5 ± 0.9 p = 0.005 6.1 ± 0.8 p = 1.000 p= 0.560
MG1655 A K-12 laboratory strain 2.6 ± 0.5 p = 0.0001 6.3 ± 1.4 p = 1.000 p= 0.546
* TBARS values are expressed in micromoles per 1011 cells. The data shown are means (mean ± SD) of three independent experiments in different batches of urine
and LB broth. Differences between means were evaluated for statistical significance using the Tukey's HSD (Honestly Significant Difference) test.
**p values of< 0.05 were considered significant. compared to ABU83972 under the same conditions.
Aubron et al. BMC Microbiology 2012, 12:120 Page 3 of 10
http://www.biomedcentral.com/1471-2180/12/120
twice with 0.9% NaCl, pelleted and stored at −20°C until
used. The cells resuspended in appropriate sonicating
buffers (see below) were disrupted by sonication on ice
for 3 min (30 s disrupt with 30 s rest) with an ultrasonic
disrupter (Sonics & Materials Inc.).
Antioxidant enzyme and glutathione assays
The pellets were sonicated in phosphate buffer, pH 7.8.
All assays, except catalase activity, were performed on a
Roche Diagnostics/Hitachi 912. Catalase activity was
determined using the Catalase Assay kit (Sigma). The
Cu-SOD activity, which corresponds to the periplasmic
SOD, was assayed using the SOD assay kit (Randox
laboratories) based on the method of Mc Cord and
Fridovich [31]. The cytosolic SOD activity, which is
effected by the Mn- and the Fe-SODs, was calculated as
the difference between the total SOD activity measured
at pH 7.8 and the Cu-SOD activity measured at pH 10.2.
The glutathione oxidoreductase was assayed by the
method of Bleuter [32]. Oxidized glutathione (GSSG) was
added and the disappearance of NADPH was monitored
at a wavelength of 340 nm. The assay of glucose-6-
phosphate-dehydrogenase (G6PDH) was based on Bleu-
ter’s method [33], where glucose-6-phosphate was added
and the reduction of NADP to NADPH was monitored at
a wavelength of 340 nm. The γ-glutamylcysteine synthe-
tase (GshA) and the glutathione synthetase (GshB) were
assayed as described previously [34]. Briefly, ADP gener-
ated by both enzymes in the presence of their substrates
was determined using a coupled assay with pyruvate
kinase, and lactate dehydrogenase. Oxidized and
reduced glutathione concentrations were assayed by
high-performance liquid chromatography (HPLC)
equipped with a colorimetric detection system, using
N-acetyl cysteine as an internal control [35]. Each ex-
periment was performed in triplicate and repeated in 3
different batches of urine. The activities of the enzymes
and the glutathione content in each sample were nor-
malized with total proteins assayed by the method of
Bradford [36].
Measurement of thiobarbituric acid reactive substances
(TBARS)
Lipid peroxidation was estimated as TBARS content.
TBARS were measured by the standard procedure using
the protocol according to the manufacturer’s instruc-
tions (OxiSelectTM TBARS Assay kit, Cells Biolabs).
When cells were either in exponential growth phase or
in stationary phase, OD600 of the cultures and TBARS
concentrations were determined. The pellets were soni-
cated in PBS buffer containing 1% Triton X-100 and
0.05% antioxidant butylated hydroxytoluene to prevent
further oxidation of lipid. Each experiment was per-
formed in duplicate and repeated in 3 different batches
of human urine and LB broth.
Statistical analysis
Differences between means of at least 3 to 9 experiments
were evaluated for statistical significance using the
Tukey's HSD (Honestly Significant Difference) test.
Figure 2 Growth of twenty-one E. coli belonging to different pathovars and phylogenetic groups. Growth in LB broth (dashed line) and in
pooled human urine (complete line). The plotted values are means of 3 independent experiments. OD600, optical density at 600 nm. Strains with
exponential phase in urine significantly different are specifically labeled.
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Non-parametric data were analysed using a Mann–
Whitney U-test. P values of< 0.05 were considered sig-
nificant. Data are presented as mean ± standard devi-
ation or as box-plots based on medians and quartiles.
Results
Growth in human urine is limiting
The growth capacity of twenty-one E. coli strains (8
UPEC, 1 EHEC, 9 ABU, 3 commensal strains) was stud-
ied (Figure 2). As expected, growth in pooled human
urine was significantly less than in LB medium, for all
strains and supplementation of urine with casaminoa-
cids improved growth (data not shown). Unlike LB
broth, urine limits cell growth. Moreover, in LB broth
as in urine, it was found that all strains produced simi-
lar growth curves. Only both strains ABU 83972 and
IAI1 grew slightly faster than four ABU strains (57, 64,
27 and 5) during the exponential phase in urine
(p< 0.0001). Surprisingly, the growth capacity of ABU
in the urine is not better than that of UPEC and com-
mensal strains.
The TBARS content differs between strains grown in urine
The content of TBARS, corresponding to the accumula-
tion of membrane lipid peroxidation products was mea-
sured during exponential growth in both culture media,
pooled human urine and LB broth (Table 1). The levels
of damage products accumulated have been used to as-
sess oxidative stress induced by intracellular ROS
[16,37]. In all cases, p values were versus ABU 83972
strain. No significant difference was observed in TBARS
content of twenty-one strains grown in LB broth while
differences occurred during growth in urine. Similar
amounts of TBARS were produced by ABU 83872 and
fourteen other strains. These amounts were significantly
higher than those produced by five other E. coli strains
(Sakai, UTI89, MG1655 and ABU 38 and 62). IAI1 with
a p value at 0.075 was at an intermediate position. These
data show that during exponential growth in urine, the
intracellular ROS level differs between strains. Further-
more, the ROS level is not linked to the phylogenetic
groups. Strains belonging to different phylogenetic
groups were found in both groups with high and low
TBARS content, respectively. In the same way, no clear
delineation between virulence categories was apparent
(Table 1). Interestingly, it also appeared that strains
which grew slightly faster or slower in urine e.g. ABU
strains 83972 and 64 respectively, exhibited similar levels
of TBARS.
ABU 83972 strain more effectively controls the level of
TBARS in urine
Changes in ROS levels produced in the exponential and
stationary growth in both pooled human urine and LB
broth were studied using a representative panel of
strains [three UPEC strains (CFT073, UTI89, 536), all
belonging to the phylogenetic B2 group, three com-
mensal strains (ED1a, IAI1, MG1655) belonging to vari-
ous phylogenetic groups, the ABU 83972 from
phylogenetic group B2 and Sakai from phylogenetic
group E] (Table 2). Due to the sampling procedure, data
obtained were subject to a new analysis of variance. The
statistical analysis performed on a limited number of
strains showed results quite similar to the first analysis.
Similar amounts of TBARS were produced by ABU
83972 and CFT073 during exponential growth in urine.
These amounts were significantly higher than those pro-
duced by the four strains IAI1, Sakai, UTI89 and
MG1655. ED1a and 536 with a p value at 0.070 and
0.048 respectively were now at an intermediate position.
No significant changes were observed in the stationary
phase of growth. As a consequence, similar amounts of
TBARS were produced during the two phases of growth
except for ABU 83972 in urine. In strain ABU 83972,
the level of TBARS was higher in the exponential phase
and decreased significantly in the stationary phase show-
ing the ability of strain ABU 83972 to control the en-
dogenous oxidative stress during growth in urine. In
contrast, all isolates grown in LB medium exhibited
similar levels of ROS regardless of the growth phase.
The behavior of the commensal strains and UPEC in
urine was also compared. As expected, no significant dif-
ference was observed in the amount of TBARS produced
(data not shown). E. coli is a diverse species, both in
terms of gene content and sequence divergence [24,38],
so we then analysed strains from the phylogenetic B2
group only, which includes both commensal and patho-
genic strains. No difference was observed between the
UPEC and the ED1a intestinal commensal strains
(p= 0.968). However, clear differences were demon-
strated in urine between the three UPEC strains selected
(5.19 ± 1.31) and the ABU strain 83972 (7.26 ± 1.03) with
a p value = 0.009.
ABU strain 83972 has better antioxidant defense capacity
than UPEC strains
The non-enzymatic and enzymatic components involved
in antioxidant defense systems (Figure 1b) were studied
during growth in pooled human urine in a subset of four
B2 UPEC and ABU strains selected from the previous
panel (CFT073, UTI89, 536 and ABU 83972) (Additional
file 1: Table S1 and Additional file 2: Table S2). To in-
crease the statistical power of our analysis, antioxidant
defense mechanisms of the three UPEC were compared
with those of ABU 83972. The results are presented
Figure 3. We also compared antioxidant defense systems
between ABU 83972 and CFT073 alone. Similar results to
those obtained for ABU 83972 and the three UPEC
Aubron et al. BMC Microbiology 2012, 12:120 Page 5 of 10
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were obtained, however, the p values were less significant
(between 0.03 and 0.15) (data not shown).
Glutathione system
The E. coli redox buffer in the cytoplasm is mostly com-
posed of the tripeptide glutathione. The intracellular
concentration is approximately 5 mM, and it is kept al-
most completely reduced (GSH). Glutathione oxidore-
ductase (Gor) reduces glutathione disulphide (GSSG),
which is formed upon oxidation, at the expense of
NADPH [14].
In urine, GSH content was low in the mid-exponential
phase and then increased in all strains (Figure 3a,
Additional file 1: Table S1 and Additional file 2: Table
S2). However, GSH content was significantly higher for
ABU 83972 than for the UPEC in the stationary phase.
No significant difference was observed in enzyme-
synthesised GSH [γ-glutamylcysteine synthetase (GshA)
and glutathione synthetase (GshB)] or GSSG content be-
tween UPEC and strain ABU 83972 or between growth
phases (Additional file 1: Table S1 and Additional file 2:
Table S2). Gor activity was significantly higher for strain
ABU 83972 than that of UPEC for all measurements and
varied significantly between mid-exponential phase and
the stationary phase (Figure 3b, Additional file 1: Table
S1 and Additional file 2: Table S2).
Enzymes responsible for the detoxification of superoxide
radicals and hydrogen peroxide
Strain ABU 83972 growth in urine was associated with
higher activity of the H2O2 detoxification system. Catalase
activity represents the peroxidase activity of several
enzymes (Figure 1b), such as hydroperoxydase I (HPI),
hydroperoxydase II (HPII) and the alkyl hydroperoxydase
(AhpC) [39,40]. Catalase activity of strain ABU 83972 was
significantly higher in mid-exponential phase and stayed
the same in stationary phase, for both groups (Figure 3d,
Additional file 1: Table S1 and Additional file 2: Table S2).
Enzymes responsible for superoxide radical O2
.- detoxifica-
tion were induced more during growth and were also more
active in this strain. All superoxide dismutases, periplasmic
and cytosolic activity increased significantly during growth,
becoming significantly greater in the stationary phase for
strain ABU 83972 only (Figure 3e, 3f). Moreover, glucose-6
phosphate dehydrogenase (G6PDH) activity of strain ABU
83972 was significantly greater in the mid-exponential
phase, and decreased to levels similar to those of UPEC
in the stationary phase (Figure 3c). This more active
Table 2 Comparison of TBARS content of eight E. coli at both phases (exponential and stationary) of growth in pooled
human urine and LB broth
Urine exponential phase Urine stationary phase Urine exponential phase
vs stationary phase
Strains TBARS* p** TBARS p p
ABU83972 7.3 ± 1.0 4.4 ± 0.4 p = 0.014
CFT073 6.3 ± 0.8 p = 0.902 4.7 ± 0.8 p = 1.000 p = 0.450
ED1a 5.2 ± 1.1 p = 0.070 5.2 ± 0.8 p = 0.927 p = 1.000
536 5.1 ± 1.0 p = 0.048 4.1 ± 0.6 p = 1.000 p = 0.993
IAI1 4.3 ± 0.7 p = 0.002 4.6 ± 0.7 p = 1.000 p = 1.000
Sakai 3.9 ± 0.4 p = 0.001 4.2 ± 0.3 p = 1.000 p = 1.000
UIT89 3.8 ± 0.6 p = 0.001 3.9 ± 0.1 p = 0.997 p = 1.000
MG1655 2.6 ± 0.5 p< 0.0001 4.0 ± 1.0 p = 0.999 p = 0.880
LB broth exponential phase LB broth stationary phase LB broth exponential phase
vs stationary phase
Strains TBARS p TBARS p p
ABU83972 6.4 ± 0.1 8.9 ± 1.6 p = 0.394
CFT073 5.9 ± 0.6 p = 0.993 6.5 ± 0.4 p = 0.458 p = 1.000
ED1a 4.9 ± 0.2 p = 0.492 6.8 ± 1.2 p = 0.581 p = 0.763
536 6.3 ± 1.7 p = 1.000 5.4 ± 1.9 p = 0.135 p = 0.998
IAI1 4.4 ± 0.3 p = 0.219 6.8 ± 0.1 p = 0.571 p = 0.465
Sakai 4.6 ± 0.7 p = 0.316 6.7 ± 1.1 p = 0.543 p = 0.635
UIT89 5.1 ± 0.1 p = 0.656 7.4 ± 0.4 p = 0.844 p = 0.540
MG1655 5.5 ± 0.1 p = 0.907 7.0 ± 0.1 p = 0.680 p = 0.942
* TBARS values are expressed in micromoles per 1011 cells. The data shown are means (mean ± SD) of three independent experiments in different batches of urine
and LB broth. Differences between means were evaluated for statistical significance using the Tukey's HSD (Honestly Significant Difference) test.
**p values of< 0.05 were considered significant. compared to ABU83972 under the same conditions.
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G6PDH could contribute to the synthesis of antioxydants
(NADPH, GSH).
As shown above, ABU 83972 growth in urine was
related to a significantly higher level of TBARS in the
mid-exponential phase. The high level of antioxidant
defenses of strain ABU 83972 resulted in a decrease of
TBARS, so there was no difference in the levels of
TBARS in the stationary phase between ABU strain
83972 and CFT073 or three UPEC.
Discussion
Our studies demonstrate that growth in urine may be
associated with endogenous oxidative stress. It is well
known that urine supports bacterial growth. Several
studies have shown that UPEC strains grow well in
human urine, whereas faecal isolates tended to grow
more poorly [19,41]. Other studies have also reported
that ABU isolates grow faster than UPEC strains [11].
However, Alteri and Mobley have recently shown that
growth in urine is not restricted to UPEC bacteria or
ABU strains. Commensal and enteropathogen E. coli
strains produced growth curves indistinguishable from
those of UPEC [42]. In agreement with their work, we
found that the ability to grow of twenty-one E. coli
belonging to different pathovars and phylogenetic
groups was nearly similar in pooled human urine. The
slow growth of a few isolates could reflect the RpoS
polymorphism in E. coli population [43,44].
Cultures were grown in microaerophilic conditions
(see Methods), where oxygen levels are similar to those
in the human urinary tract [18,45]. This reduction in
oxygen content leads to a redistribution of metabolic
fluxes between fermentation and respiration [46]. Such a
shift may decrease the respiratory chain-mediated gener-
ation of ROS. Moreover, in our culture conditions, auto-
xidizable enzymes such as L-aspartate oxidase and
fumarate reductase should not contribute significantly to
the formation of H2O2. However, metabolic reactions
that generate nearly two-thirds of H2O2 are not yet iden-
tified [47]. Therefore, we can expect that changes in
metabolic fluxes generate different ROS levels. Analysis
of metabolic capabilities in a collection of 153 E. coli
natural isolates [48] and of gene expression in strains
ABU 83972 and CFT073 grown exponentially in urine
[49] revealed significant differences in their metabolic
capacities. These metabolic changes could therefore gen-
erate different ROS levels in our isolates.
Urine is a complex growth medium and E. coli must
adapt to stress imposed by this tough environment. The
high osmolality, high urea concentration, low pH and
the limitation of certain components could provoke an
oxidative response. To protect from these highly reactive
intermediates, cells possess a defense system consisting
of both enzymatic and non- enzymatic antioxidants that
scavenge them. Nevertheless, under several situations,
the rate of generation of ROS exceeds that of their re-
moval and oxidative stress occurs. The levels of damage
(a) (b) (c)
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Figure 3 Comparison of antioxidant defense mechanisms between UPEC (CFT073, UTI 89 and 536) and ABU 83972 strains at both
phases of growth. (a) Content of glutathione (GSH), (b) Glutathione oxidoreductase (Gor) activity, (c) Activity of glucose 6 phosphate
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products accumulated (estimated as TBARS concentra-
tion) mirror the intensity of oxidative stress. Our results
demonstrate that E. coli strains can respond very differ-
ently to stress imposed by urine. TBARS measurements
revealed that many E. coli are exposed to ROS during
exponential growth in urine. Surprisingly, this is the case
of ABU strain 83972 that is very well adapted to growth
in the urinary tract [11]. In contrast, two other ABU
strains 38 and 62, as UTI89, Sakai and MG1655 showed
a lower oxidative damage to lipid. No clear correlation
between ROS level and the phylogroups or pathogenic
group was apparent.
ABU isolates form a heterogenous group. Individual
ABU strains display many differences between them in
their genome contents and in virulence-associated genes
such as LPS, microcin, aerobactin, and mobility [11,27].
Interestingly, our study shows that the two ABU strains
(38 and 62) belonging to the group B1, differ from other
by the low ROS production in urine.
The commensal-like ABU 83972 strain and the patho-
genic strain CFT073 are very closely related and belong
to the same B2 subgroup II [25], or to the same se-
quence type 73 clonal group [4]. These both strains are
genetically very similar and differ only by a few hundred
genes [50]. However, strain ABU 83972 is able to out-
compete CFT073 strain in urine [51]. The results pre-
sented herein indicate that both strains undergo an
oxidative stress during the exponential growth. Nonethe-
less, ABU 83972 strain displays more active antioxidant
defenses which led to a significant decrease in ROS level
in stationary phase. Our results agree with the gene ex-
pression profiling in strains ABU 83972 and CFT073 in
urine, which showed that sodA, encoding superoxide
dismutase and ahpC, encoding hydroperoxide reductase
are significantly up-regulated [49,52]. Interestingly the
highest expression values were obtained in ABU 83972
strain [49]. To further explore the oxidative response,
other studies will be performed to examine the contribu-
tion of each factor involved in this response and the im-
portance of metabolic changes in these isolates.
The UPEC strains CFT073 (urosepsis/pyelonephritis
isolate), 536 (pyelonephritis, B2 subgroup III) and UTI89
(cystitis, B2 subgroup IX) [25] are very well adapted for
growth in the human urinary tract and present similar
antioxidant defense systems. However, a clear distinction
can be drawn between them. Strains CFT073 and 536 be-
have similarly with respect to ROS formation in exponen-
tial phase in contrast to UTI89 (p= 0.016). The metabolic
fluxes could be distributed differently in UTI89, which
may decrease the endogenous production of ROS.
The more efficient antioxidant metabolism related to
greater exposure to endogenous oxidative stress may be
responsible for the difference in lifestyle between ABU
83972 and CFT073 strains. ABU 83972 strain exploits
urine more efficiently than UPEC strains [11]. Previous
study has shown that a more active antioxidant defense
system increases the capacity to colonize the bladder [53].
Thus, a high level of antioxidant defenses associated to
fast growth in the urine (this work), low abundance of fim-
briae, and possible biofilm formation [54] could explain
why ABU83972 strain is able to establish a long-term bac-
teriuria. Additionally, ROS are implicated in DNA muta-
genesis which may be adaptive as reported in biofilm for
antibiotic-resistance [55], or more generally, during starva-
tion [56]. The high levels of ROS in ABU strain 83972
may explain the genetic alterations described [27].
Conclusions
We showed that growth in human urine of many E. coli
strains belonging to different phylogenetic groups and
pathovars was associated with an endogenous oxidative
stress. The growth of ABU strain 83972 was associated
with a high level of ROS and more active antioxidant
defenses. The increased level of ROS may be responsible
for adaptive mutations. A more active antioxidant defense
system could increase the capacity to colonize the bladder.
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